Marine Sølling Ramsing

PPIs may have adverse effects in patients with cirrhosis of the liver, but in the last two decades, studies have shown conflicting results. Our aim was to calculate the prevalence and the incidence of proton pump inhibitor use among all patients with cirrhosis in Denmark during this period. We showed that 40% of all patients with cirrhosis used PPIs and that many patients initiated treatment after they were diagnosed with cirrhosis.

Back to Journals » Clinical Epidemiology » Volume 15 Authors Ramsing MS , Kraglund F , Jepsen P Received 17 December 2022 Accepted for publication 9 March 2023 Published 1 April 2023 Volume 2023:15 Pages 435—446 DOI https://doi.org/10.2147/CLEP.S401862 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Henrik Toft Sørensen Marine Sølling Ramsing, Frederik Kraglund, Peter Jepsen Department of Hepatology and...